Home › Funds › Birchview Capital, LP › VYGR

Birchview Capital, LP position in VYGR

VOYAGER THERAPEUTICS INC · Health Care

Birchview Capital, LP reported holding 224,918 shares of VYGR (VOYAGER THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$603K, representing 0.36% of its reported portfolio and ranking #46 among its reported holdings. Birchview Capital, LP has disclosed VYGR holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

Latest position (Q3 2026)224.92K sh
Reported value held$602.78K
Portfolio Weight0.36%
First reportedQ3 2025
Last changeAdd
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Birchview Capital, LP's VYGR position evolved

Birchview Capital, LP first disclosed a stake in VYGR in Q3 2025 at 134,918 shares (US$630K). Across 5 filings, Birchview Capital, LP increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 224,918 shares valued at US$603K — an increase of 149,771 shares quarter over quarter.. Notable position changes include a 44% trim in Q4 2025 (shares fell 2% over the following quarter), a 199% increase in Q3 2026 (shares fell 35% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2025 134.92K $630.07K New
Q4 2025 74.92K $294.43K Reduce
Q1 2026 74.92K $289.18K Hold
Q2 2026 75.15K $263.01K Hold
Q3 2026 224.92K $602.78K Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VYGR and 13F data

VYGR (VOYAGER THERAPEUTICS INC) is a Health Care company. 15 other funds we track also report a position in VYGR — the largest reported positions include Opaleye Management Inc. (US$4.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VYGR

All VYGR fund holders →

FAQ

How long has Birchview Capital, LP held VYGR?

Birchview Capital, LP has disclosed VYGR holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

What is Birchview Capital, LP's current position in VYGR?

As of Q3 2026, Birchview Capital, LP holds 224.92K shares of VYGR (VOYAGER THERAPEUTICS INC), valued at $602.78K, representing 0.36% of its reported portfolio and ranking #46.

Has Birchview Capital, LP been buying or selling VYGR?

In the latest 13F filing (Q3 2026), Birchview Capital, LP increased its position in VYGR.

Which other funds hold VYGR?

Other major institutional holders of VYGR include Opaleye Management Inc., among 15 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.